Medicare Covers GLP-1 Weight-Loss Drugs Starting July 1
For the first time, qualifying Medicare members can access GLP-1 weight-loss drugs for just $50/month. Here's what older adults should know.
Big news if you're on Medicare and have been eyeing those GLP-1 weight-loss drugs everyone keeps talking about — starting July 1, you may finally be able to get them without paying full price out of pocket. Qualifying Medicare beneficiaries will be able to access these medications for around $50 a month, marking the first time the program has covered GLP-1s specifically for weight loss.
For context, GLP-1s (glucagon-like peptide-1 receptor agonists) are a class of drugs that have taken the weight-loss world by storm. Brand names like Ozempic and Wegovy work by mimicking a gut hormone that tells your brain you're full. Without insurance, they can run hundreds or even thousands of dollars per month, so a $50 Medicare price point is a meaningful shift for older Americans on fixed incomes.
Read more Working in Retirement While Collecting Social Security: What to Know →
Before you call your doctor, though, there are some real tradeoffs worth understanding. These drugs come with well-documented side effects — nausea, vomiting, and digestive discomfort are common, especially early on. There's also the issue of muscle loss. When people drop weight quickly, they don't just shed fat; they can lose lean muscle mass too, which is a particular concern for older adults who are already at higher risk for conditions like sarcopenia.
If you're a Medicare beneficiary thinking about going this route, it's worth having an honest conversation with your doctor about whether you qualify under the new coverage rules and how to manage potential side effects. Pairing the medication with adequate protein intake and resistance exercise can help protect muscle — something your care team can help you plan.
Continue reading at MarketWatch.com
